Hospitals have long dominated the realms of infection control and antibiotic overuse. Ambulatory surgery centers (ASCs), which typically release patients the same day of a procedure, use antibiotics less frequently than other facilities, and most do not have an antimicrobial stewardship program. However, some ASC leaders and organizations are encouraging…
Editor's Note The American College of Radiology (ACR) on March 11 issued a recommendation that CT scans not be used as a first-line screening test to diagnose COVID-19, the March 11 AuntMinnie.com reports. Though early reports from China indicated that CT could detect COVID-19, even when DNA tests were negative,…
Editor's Note This study led by Johns Hopkins researchers provides additional evidence of a median incubation period of approximately 5.1 days for the novel coronavirus disease 2019 (COVID-19). Of 181 confirmed cases of COVID-19 (from China and other countries) with identifiable exposure and symptom onset windows in the analysis, the…
Editor's Note The US Department of Health and Human Services (HHS) on March 9 released two interoperability rules, which will give patients direct access to their healthcare data. These rules mark the most extensive healthcare data sharing policies the federal government has implemented, requiring public and private entities to share…
Editor's Note The Food and Drug Administration (FDA) on March 6 identified the recall by Becton Dickinson (BD)/CareFusion 303 of its Alaris System Infusion Pumps and Modules as Class I, the most serious. The recall was initiated because of multiple system errors, software errors, and use-related errors. The errors can…
Editor's Note This retrospective, multicenter study from four hospitals in Wuhan, China, found that Novel Coronavirus 2019 (COVID-19) specific guidelines for emergency surgical procedures in patients with confirmed or suspected COVID-19 infection can effectively prevent cross-infection in the OR. The guidelines include: negative pressure ORs level 3 protective measures for…
Editor's Note In a March 4 press release, the Centers for Medicare & Medicaid Services (CMS) called on all healthcare providers to make sure they are implementing infection control practices, which they are required to maintain at all times, in an effort to limit the spread of the Novel Coronavirus…
Editor's Note The Food & Drug Administration (FDA) on March 2 announced that it had joined with the Centers for Disease Control and Prevention (CDC) to make more respirators, including certain N95s, available to healthcare personnel during the coronavirus (COVID-19) outbreak. Currently, the majority of respirators are used in industrial…
Editor's Note The Food & Drug Administration (FDA) on February 27 identified the recall by King Systems of its King Vision Video Laryngoscope Adapter (size ½) as Class I, the most serious. The recall was initiated because all devices from the affected lots show a reversed image on the display,…
Editor's Note The Centers for Disease Control and Prevention (CDC) on February 27 updated its guidance for healthcare professionals evaluating and reporting patients under investigation for the novel coronavirus (COVID-19). The CDC has developed clinical criteria to guide patient evaluation based on what is known about Middle East Respiratory Syndrome…